Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Celera acquires Axys Pharmaceuticals

Executive Summary

Applera's Celera Genomics acquired medicinal and structural chemistry company Axys Pharmaceuticals for $174mm in Celera stock. The deal values each Axys share at $4.65, a 35% premium over the pre-announcement closing price, and involves a collar provision.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Includes Contract
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register